Venmax Drugs and Pharmaceuticals Ltd — Important, 06-04-2026: Company Update

The company has received an annual declaration from its Promoters and Promoter Group for the financial year ended March 31, 2026. They have confirmed that no encumbrance, direct or indirect, has been made on the shares they hold in the company. This annual transparency update is significant for shareholders, as it provides assurance regarding the stability and unpledged status of the promoter's stake, reflecting their continued commitment to the company's future.